The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19

Immunosuppression (IS) and autoimmune disease (AD) are prevalent in patients with severe coronavirus disease 2019 (COVID-19), but their impact on its clinical course is unknown. We investigated relationships between IS, AD, and outcomes in patients hospitalized with COVID-19. Data on consecutive adm...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Immunol
Hlavní autoři: Monreal, Enric, Sainz de la Maza, Susana, Fernández-Velasco, Jose Ignacio, Natera-Villalba, Elena, Rita, Claudia Geraldine, Rodríguez-Jorge, Fernando, Beltrán-Corbellini, Álvaro, Iturrieta-Zuazo, Ignacio, Rodríguez de Santiago, Enrique, Espiño, Mercedes, de Andrés, Ana, Fortún, Jesús, Barbero, Esther, Vázquez, Mónica, Fernández Lucas, Milagros, Manzano, Luis, Montero-Errasquín, Beatriz, Costa-Frossard, Lucienne, Masjuan, Jaime, Villar, Luisa María
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685686/
https://ncbi.nlm.nih.gov/pubmed/33236261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-020-00927-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky